35 participants
A Dose-Escalation Study to Assess the Safety and Tolerability of LX214 Ophthalmic Solution in Healthy Volunteers, Followed by an Open-Label Evaluation of LX214 in Patients With Keratoconjunctivitis Sicca (KCS)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2012-06-22
- Start Date:
- 2009-02-28
- Completion:
- 2009-03-31
Conditions
- Keratoconjunctivitis Sicca
Interventions
- DRUG
No Results Yet